Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein

被引:11
作者
Lewis, H [1 ]
Webster, K [1 ]
Sanchez-Perez, AM [1 ]
Gaston, K [1 ]
机构
[1] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England
关键词
D O I
10.1099/0022-1317-80-8-2087
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human papillomavirus type 16 (HPV-16) is a DNA tumour virus that has been implicated in the development of cervical cancer. The HPV-16 E2 protein binds to four sites that are present upstream of the viral P97 promoter and regulates transcription of the E6 and E7 oncogenes. Here, it is shown that cellular transcription factors bind to two of these E2 sites. One cellular E2 site-binding factor, which is here named CEF-1, binds tightly to E2 site 1. CEF-2, an unrelated cellular E2 site-binding factor, binds tightly to E2 site 3. Transient transfection studies performed in the absence of the E2 protein showed that mutations that blocked the binding of CEF-1 to E2 site 1 or CEF-2 to E2 site 3 significantly reduced P97 promoter activity. Further characterization of CEF-1 indicated that this factor has not previously been identified and that CEF-1 and E2 competed for binding at E2 site 1.
引用
收藏
页码:2087 / 2096
页数:10
相关论文
共 48 条
[11]   ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI [J].
DIGNAM, JD ;
LEBOVITZ, RM ;
ROEDER, RG .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1475-1489
[12]   PREVALENCE OF DELETIONS OF YY1-BINDING SITES IN EPISOMAL HPV-16 DNA FROM CERVICAL CANCERS [J].
DONG, XP ;
STUBENRAUCH, F ;
BEYERFINKLER, E ;
PFISTER, H .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (06) :803-808
[13]   NEW LYMPHOCYTE-B-SPECIFIC ENHANCER-BINDING PROTEIN [J].
DORN, A ;
BENOIST, C ;
MATHIS, D .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (01) :312-320
[14]   THE FUNCTIONAL BPV-1 E2 TRANS-ACTIVATING PROTEIN CAN ACT AS A REPRESSOR BY PREVENTING FORMATION OF THE INITIATION COMPLEX [J].
DOSTATNI, N ;
LAMBERT, PF ;
SOUSA, R ;
HAM, J ;
HOWLEY, PM ;
YANIV, M .
GENES & DEVELOPMENT, 1991, 5 (09) :1657-1671
[15]   A PAPILLOMAVIRUS DNA FROM A CERVICAL-CARCINOMA AND ITS PREVALENCE IN CANCER BIOPSY SAMPLES FROM DIFFERENT GEOGRAPHIC REGIONS [J].
DURST, M ;
GISSMANN, L ;
IKENBERG, H ;
ZURHAUSEN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12) :3812-3815
[16]   THE PHYSICAL STATE OF HUMAN PAPILLOMAVIRUS TYPE-16 DNA IN BENIGN AND MALIGNANT GENITAL TUMORS [J].
DURST, M ;
KLEINHEINZ, A ;
HOTZ, M ;
GISSMANN, L .
JOURNAL OF GENERAL VIROLOGY, 1985, 66 (JUL) :1515-1522
[17]   THE HUMAN PAPILLOMA VIRUS-16 E7-ONCOPROTEIN IS ABLE TO BIND TO THE RETINOBLASTOMA GENE-PRODUCT [J].
DYSON, N ;
HOWLEY, PM ;
MUNGER, K ;
HARLOW, E .
SCIENCE, 1989, 243 (4893) :934-937
[18]   THE E6/E7 PROMOTER OF HUMAN PAPILLOMAVIRUS TYPE-16 IS ACTIVATED IN THE ABSENCE OF E2 PROTEINS BY A SEQUENCE-ABERRANT SP1 DISTAL ELEMENT [J].
GLOSS, B ;
BERNARD, HU .
JOURNAL OF VIROLOGY, 1990, 64 (11) :5577-5584
[19]   THE UPSTREAM REGULATORY REGION OF THE HUMAN PAPILLOMA VIRUS-16 CONTAINS AN E2-PROTEIN-INDEPENDENT ENHANCER WHICH IS SPECIFIC FOR CERVICAL-CARCINOMA CELLS AND REGULATED BY GLUCOCORTICOID HORMONES [J].
GLOSS, B ;
BERNARD, HU ;
SEEDORF, K ;
KLOCK, G .
EMBO JOURNAL, 1987, 6 (12) :3735-3743
[20]   COOPERATIVITY IN-VIVO BETWEEN THE E2 TRANSACTIVATOR AND THE TATA BOX-BINDING PROTEIN DEPENDS ON CORE PROMOTER STRUCTURE [J].
HAM, J ;
STEGER, G ;
YANIV, M .
EMBO JOURNAL, 1994, 13 (01) :147-157